Bioinformatics analysis of macrophage-associated genes reveals prognostic signatures and immune landscape in gastric cancer
- PMID: 41264178
- PMCID: PMC12748356
- DOI: 10.1007/s12672-025-04019-4
Bioinformatics analysis of macrophage-associated genes reveals prognostic signatures and immune landscape in gastric cancer
Abstract
Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide. The interaction between macrophages and the tumor immune microenvironment (TME) plays a critical role in disease progression and patient prognosis. In this study, we conducted a comprehensive bioinformatics analysis to identify macrophage-associated prognostic genes and construct a predictive risk model in GC. Using transcriptome data from TCGA (n = 350 tumors, 31 controls) and GEO datasets (GSE84437, n = 483; GSE183904), we applied differential expression analysis (DESeq2), weighted gene co-expression network analysis (WGCNA), single-cell RNA sequencing (Seurat), and Cox-LASSO regression to screen for key prognostic markers. Three genes-GPX3, SERPINE1, and SPARC-were identified and used to build a risk score model. Patients were stratified into high- and low-risk groups. Kaplan-Meier analysis showed significantly shorter survival in the high-risk group (HR = 2.35, p < 0.001). The model achieved strong predictive performance with area under the curve (AUC) values of 0.73, 0.70, and 0.68 at 1, 3, and 5 years, respectively. Immune infiltration analysis using CIBERSORT revealed that GPX3 and SPARC were positively correlated with plasma cells and negatively with M0 macrophages. A nomogram incorporating risk score, age, and N/M stage further improved prognostic accuracy. Drug sensitivity analysis (pRRophetic) identified 27 compounds with differential predicted IC50 values between risk groups.Our study demonstrates that macrophage-associated gene signatures are robust predictors of GC prognosis. These findings provide novel insights into immune regulation and potential therapeutic targets in gastric cancer.
Keywords: Gastric cancer; Macrophage; Nomogram; Risk model.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the Fourth Affiliated Hospital of Nanjing Medical University (Approval number: 20241024-K113). Consent for publication: All authors have read and approved the final version of the manuscript and consent to its publication. Competing interests: The authors declare no competing interests.
Figures
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Stat 2021 CA Cancer J Clin. 2021;71:7–33. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous